2012 Global Papillomavirus Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 196 pages and 10 tables.
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 196 pages and 10 tables.
I. INTRODUCTION
II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT
X. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Ortho-Clinical Diagnostics/J&J
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis
PerkinElmer
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
LIST OF TABLES
France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment